Literature DB >> 30731020

Gabapentin-related Deaths: Patterns of Abuse and Postmortem Levels.

Amy M Tharp1, Kathrin Hobron2, Trista Wright3.   

Abstract

Gabapentin, a GABA analogue, is a nonopioid prescribed for seizure control and neuralgic pain. Its abuse for recreational purposes has been increasing in recent years as the number of prescriptions also increases. In our series, we review 104 cases of decedents who tested positive for gabapentin in postmortem blood samples and an additional 53 nonfatal cases of motor vehicle drivers suspected of driving under the influence. In 47.1% of the fatality cases, gabapentin was directly involved in death. Most gabapentin fatalities had several other intoxicants present (opioids, over-the-counter medications, antianxiety, and antidepressant medications). In cases in which gabapentin was determined to be a cause of death, the blood concentrations ranged from 1.1 to 134.0 mg/L. Persons who died of a gabapentin-related drug death were prescribed the drug legitimately 91.4% of the time, with 84.2% of those also having a known prior history of abuse or misuse of prescription medications.
© 2019 American Academy of Forensic Sciences.

Entities:  

Keywords:  death; forensic science; gabapentin; overdose; toxicity; toxicology

Mesh:

Substances:

Year:  2019        PMID: 30731020     DOI: 10.1111/1556-4029.14021

Source DB:  PubMed          Journal:  J Forensic Sci        ISSN: 0022-1198            Impact factor:   1.832


  4 in total

1.  Prevalence of and Factors Associated with Gabapentinoid Use and Misuse Among Texas Medicaid Recipients.

Authors:  Elizabeth A Ibiloye; Jamie C Barner; Kenneth A Lawson; Karen L Rascati; Kirk E Evoy; Alyssa M Peckham
Journal:  Clin Drug Investig       Date:  2021-02-12       Impact factor: 2.859

2.  Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update.

Authors:  Kirk E Evoy; Sarvnaz Sadrameli; Jillian Contreras; Jordan R Covvey; Alyssa M Peckham; Megan D Morrison
Journal:  Drugs       Date:  2021-01       Impact factor: 9.546

3.  Trends in Gabapentin Prescribing in a Commercially Insured U.S. Adult Population, 2009-2016.

Authors:  Nathan J Pauly; Chris Delcher; Svetla Slavova; Eric Lindahl; Jeff Talbert; Patricia R Freeman
Journal:  J Manag Care Spec Pharm       Date:  2020-03

4.  Fatalities associated with gabapentinoids in England (2004-2020).

Authors:  Nicola J Kalk; Ching-Ting Chiu; Rasa Sadoughi; Heli Baho; Bryn D Williams; David Taylor; Caroline S Copeland
Journal:  Br J Clin Pharmacol       Date:  2022-04-25       Impact factor: 3.716

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.